Merger Accretion And Dilution Intuition

Reviewed by Fallon Han· Updated 2026-06-01 06:05:33.032

This conversation was generated using Cook'd AI's career assistant and reviewed by Fallon Han from our editorial team for accuracy.

I'm a penultimate-year finance major in Hong Kong, and I'm trying to prep for boutique M&A interviews while juggling a part-time internship. Can you walk me through a concrete merger example? I get the headline idea of accretion and dilution, but I do not understand why a deal can look attractive under one set of assumptions and unattractive under another.

Absolutely. Let's use a simple example so the intuition is clear. Say Company A buys Company B: - Company A EPS: 5.00 - Company B EPS: 2.00 - A can issue new debt at 5 percent or use cash, or issue stock - A expects to generate 20 million of annual synergies - B has 100 million shares outstanding The key question is not just whether the target is cheap. It is whether the combined net income per share after financing the deal is above or below A's stand-alone EPS. If A pays mostly with stock, it shares the combined earnings with more shares, so dilution is more likely. If A pays with debt, there are more interest costs, but fewer new shares. That is why the financing mix changes the accretion or dilution outcome. The deal can look attractive if the synergies are high enough to offset the financing cost and any premium paid. It can look unattractive if the synergies are too small or if the funding cost overwhelms them.

Can you show me the actual mechanics? I want to see how the same deal flips from accretive to dilutive when the synergy assumption changes, because that is what confuses me in interviews.

Sure. Let's keep it simple and focus on the intuition. Assume: - A has 100 million shares and net income of 500 million, so EPS is 5.00 - B has net income of 100 million - A pays 2.0 billion for B - A issues debt at 5 percent, so annual interest is 100 million - Tax rate is 25 percent - Shares do not change if we use debt financing Now compare two synergy cases. Case 1: Synergies of 50 million pre-tax - After tax, that is 37.5 million - Incremental earnings from B and synergies: 100 + 37.5 = 137.5 million - Subtract after-tax interest cost: 100 times 75 percent = 75 million - Net contribution to earnings: 62.5 million - Combined net income: 562.5 million - EPS: 5.625 That is accretive because EPS rises from 5.00 to 5.625. Case 2: Synergies of 0 - Incremental earnings: 100 million - Subtract after-tax interest: 75 million - Net contribution: 25 million - Combined net income: 525 million - EPS: 5.25 Still accretive in this simplified case, but much less so. Now if the purchase price were higher, or if the debt cost were higher, or if the target's earnings were lower, the same deal could turn dilutive. So in interviews, they are testing whether you understand that accretion depends on the spread between the target's earnings plus synergies and the financing cost, all divided by the new share count if stock is used.

So if debt usually avoids dilution from new shares, why do interviewers still say stock can be better sometimes? I thought debt was always better for accretion.

That is a very common trap. Debt is not automatically better. Debt can improve accretion in the short term because it avoids issuing new shares. But too much debt creates interest expense and may increase financial risk, which can lower valuation and hurt the deal. Stock can be better when: - The buyer's stock is expensive relative to the target - The target's business is riskier and the buyer wants to preserve balance sheet flexibility - The deal premium is high and debt financing would make the transaction too expensive - Management wants to maintain leverage capacity for future deals So the right financing mix depends on the trade-off between EPS impact, cost of capital, and risk. In an interview, a strong answer is not 'debt is always best.' It is 'debt can be more accretive mechanically, but the optimal mix depends on valuation, leverage, and strategic flexibility.'

How would I phrase that in a boutique M&A interview in Hong Kong if they ask me why a merger looks accretive on paper but still might not be good? I want a tight answer, not a textbook one.

You could say: 'Accretion is only a first-pass screen. A deal can boost EPS because of financing structure or near-term synergies, but still be weak strategically if the purchase premium is too high, the synergy case is unrealistic, or the added leverage creates downside risk. I would look at whether the combined company creates durable value after accounting for execution risk and the cost of capital, not just whether EPS ticks up.' That answer shows you know the mechanics and the judgment layer. If you want to sound even sharper, add one sentence on financing mix: 'For example, stock may be less accretive mechanically, but it can preserve flexibility and reduce financial strain if the target is volatile or if rates are high.'

One more thing: if synergies are the main driver, what makes interviewers skeptical of them? I keep hearing that synergy assumptions are where deals get sold too aggressively.

Exactly. Synergies are often the most optimistic part of a merger case. Interviewers get skeptical when the synergy logic is vague, because real synergy usually comes from specific sources: - Cost cuts, like overlapping headcount or systems - Revenue synergies, like cross-selling, which are harder to prove - Financing or tax benefits, which can be less stable They worry about three things: - Timing: synergies may take years to realize - Integration risk: teams may not work smoothly - Overlap: management may count benefits that are harder to capture than they sound So if a deal turns from attractive to unattractive as synergies go from, say, 100 million to 25 million, that tells you the transaction is highly dependent on a fragile assumption. In interviews, it is good to say that a real buyer should underwrite conservative synergies and then test whether the deal still works without heroic assumptions. For your situation, the clean takeaway is: if the merger only works with aggressive synergies and heavy debt, that is a warning sign, not a win.